( September 3, 2026, 06:04 GMT | Official Statement) -- MLex Summary: China’s antitrust authorities will continue a nationwide enforcement campaign focused on platform companies, active pharmaceutical ingredients, public utilities and sectors affecting people’s livelihoods, the State Administration for Market Regulation said in a statement published Thursday. Officials meeting in Dalian, Liaoning Province, on Wednesday and Thursday reviewed progress in the campaign and discussed next steps, including efforts to curb “involution-style” competition, support the development of a unified national market and protect fair competition. Market-regulation authorities from Beijing, Liaoning, Jiangsu, Shandong, Chongqing and Shaanxi attended the meeting.Statement follows (in Chinese)....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.